4-Dimethylaminophenol    B-Aniline114754505

robenacoxib    B-Aniline114754505
–    O
nonsteroidal    O
anti    O
-    O
inflammatory    O
drug    O
(    O
NSAID    O
)    O

Zacopride    B-Aniline114754505

In    O
September    O
2013    O
,    O
the    O
FDA    O
announced    O
that    O
Zoetis    O
and    O
Fleming    O
Laboratories    O
would    O
voluntarily    O
withdraw    O
current    O
roxarsone    O
,    O
arsanilic    B-Aniline114754505
acid    I-Aniline114754505
,    O
and    O
carbarsone    B-Aniline114754505
approvals    O
,    O
leaving    O
only    O
nitarsone    O
approvals    O
in    O
place    O
.    O

Derivatives    O
of    O
phenylarsonic    O
acid    O
(    O
C6H5AsO(OH)2    O
)    O
are    O
used    O
as    O
feed    O
additives    O
for    O
livestock    O
,    O
including    O
4-hydroxy-3-nitrobenzenearsonic    O
acid    O
(    O
3-NHPAA    O
or    O
Roxarsone    O
)    O
,    O
ureidophenylarsonic    O
acid    O
,    O
and    O
"p"-arsanilic    B-Aniline114754505
acid    I-Aniline114754505
.    O

Anton    O
Breinl    O
-    O
discovered    O
that    O
atoxyl    B-Aniline114754505
cures    O
trypanosomiasis    O
and    O
established    O
the    O
first    O
Australian    O
Institute    O
of    O
Tropical    O
Medicine    O
in    O
Townsville    O
,    O
Queensland    O
,    O
Australia    O

It    O
used    O
to    O
be    O
used    O
as    O
a    O
food    O
dye    O
,    O
designated    O
in    O
Europe    O
by    O
the    O
E    O
number    O
E105    B-Aniline114754505
.    O

Treatment    O
of    O
2,4-dimethylaniline    B-Aniline114754505
with    O
diketene    O
gives    O
an    O
acetoacetylated    O
aniline    O
.    O

Oil    B-Aniline114754505
Yellow    I-Aniline114754505
R    I-Aniline114754505

Other    O
common    O
tracking    O
dyes    O
are    O
xylene    B-Aniline114754505
cyanol    I-Aniline114754505
,    O
which    O
has    O
lower    O
mobility    O
,    O
and    O
Orange    O
G    O
,    O
which    O
has    O
a    O
higher    O
mobility    O
.    O

The    O
loading    O
buffer    O
also    O
includes    O
colored    O
dyes    O
such    O
as    O
xylene    B-Aniline114754505
cyanol    I-Aniline114754505
and    O
bromophenol    O
blue    O
used    O
to    O
monitor    O
the    O
progress    O
of    O
the    O
electrophoresis    O
.    O

Paracaine    B-Aniline114754505
,    O
tetracaine    O
,    O
bupivacaine    O
,    O
lidocaine    O
etc    O
.    O

Kainair    B-Aniline114754505

A    O
culling    O
with    O
the    O
bird    O
poison    O
(    O
avicide    O
)    O
DRC-1339    B-Aniline114754505
received    O
national    O
attention    O
after    O
USDA    O
employees    O
dispensed    O
the    O
substance    O
in    O
Griggstown    O
,    O
New    O
Jersey    O
to    O
kill    O
an    O
estimated    O
5,000    O
starlings    O
that    O
plagued    O
feed    O
lots    O
and    O
dairies    O
on    O
local    O
farms    O
.    O

N,N'-di-2-butyl-1,4-phenylenediamine    B-Aniline114754505
,    O
an    O
antioxidant    O
.    O

Examples    O
include    O
benzocaine    O
,    O
butamben    B-Aniline114754505
,    O
dibucaine    O
,    O
lidocaine    O
,    O
oxybuprocaine    B-Aniline114754505
,    O
pramoxine    O
,    O
proparacaine    B-Aniline114754505
,    O
proxymetacaine    B-Aniline114754505
,    O
and    O
tetracaine    O
(    O
also    O
named    O
amethocaine    O
)    O
.    O

"N","N"-Diethylaniline    B-Aniline114754505
was    O
used    O
by    O
Aum    O
Shinrikyo    O
for    O
acid    O
reduction    O
.    O

Bicalutamide    O
and    O
flutamide    O
,    O
though    O
not    O
nilutamide    O
,    O
can    O
also    O
be    O
classified    O
as    O
toluidide    B-Aniline114754505
.    O

Winkler    O
photometric    O
method    O
is    O
a    O
colour    O
-    O
reaction    O
using    O
p    O
-    O
toluidine    B-Aniline114754505
and    O
barbituric    O
acid    O
(    O
DIN    O
10751    O
-    O
1    O
)    O
.    O

The    O
Robinsons    O
disproved    O
many    O
of    O
the    O
prevailing    O
theories    O
about    O
the    O
Fischer    O
Indole    O
Mechanism    O
by    O
showing    O
that    O
the    O
reaction    O
went    O
unperturbed    O
in    O
the    O
presence    O
of    O
other    O
aromatic    O
amines    O
such    O
as    O
p    O
-    O
toluidine    B-Aniline114754505
.    O

The    O
more    O
complex    O
phenazines    O
,    O
such    O
as    O
the    O
naphthophenazines    O
,    O
naphthazines    O
,    O
and    O
naphthotolazines    O
,    O
may    O
be    O
prepared    O
by    O
condensing    O
ortho-diamine    B-Aniline114754505
with    O
ortho    O
-    O
quinones    O
or    O
by    O
the    O
oxidation    O
of    O
an    O
ortho    O
-    O
diamine    O
in    O
the    O
presence    O
of    O
α-naphthol    O
,    O
and    O
by    O
the    O
decomposition    O
of    O
ortho    O
-    O
anilido-(-toluidido-    O
et    O
cetera)-    O
azo    O
compounds    O
with    O
dilute    O
acids    O
.    O

In    O
the    O
salol    O
reaction    O
,    O
phenyl    O
salicylate    O
reacts    O
with    O
o-toluidine    B-Aniline114754505
in    O
1,2,4-trichlorobenzene    O
at    O
elevated    O
temperatures    O
to    O
the    O
corresponding    O
amide    O
"    O
o    O
-    O
Salicylotoluide    O
"    O
.    O

AR-231,453    B-Aniline114754505

Mice    O
also    O
show    O
a    O
decrease    O
in    O
FAM185a    O
expression    O
in    O
tissues    O
that    O
have    O
been    O
treated    O
with    O
Reversine    B-Aniline114754505
,    O
indicating    O
the    O
protein    O
's    O
potential    O
role    O
relates    O
to    O
stem    O
cell    O
differentiation    O
during    O
development    O
.    O

First    O
synthesis    O
of    O
Dapsone    O
from    O
4,4'-Thiodianiline    B-Aniline114754505
&    O
Wittman    O
,    O
1908    O
.    O

Oryzalin    B-Aniline114754505
is    O
an    O
herbicide    O
of    O
the    O
dinitroaniline    B-Aniline114754505
class    O
.    O

With    O
heat    O
,    O
aminosalicylic    O
acid    O
is    O
decarboxylated    O
to    O
produce    O
CO2    O
and    O
3-aminophenol    B-Aniline114754505
.    O

3-(Trifluoromethyl)aniline    B-Aniline114754505
is    O
a    O
compound    O
with    O
the    O
molecular    O
formula    O
CF3C6H4NH2    O
.    O

2,5-Xylidine    B-Aniline114754505
is    O
an    O
organic    O
compound    O
with    O
the    O
formula    O
C6H3(CH3)2NH2    O
.    O

It    O
is    O
marketed    O
as    O
Uvasorb    B-Aniline114754505
HEB    I-Aniline114754505
by    O
3V    O
Sigma    O
.    O

Padimate    B-Aniline114754505
O    I-Aniline114754505

Anilopam    B-Aniline114754505

Alinidine    B-Aniline114754505
(    O
ST567    B-Aniline114754505
)    O
is    O
a    O
negative    O
chronotrope    O
that    O
was    O
developed    O
in    O
the    O
1970s    O
and    O
1980s    O
.    O

Chloroxuron    B-Aniline114754505

Risocaine    B-Aniline114754505
(    O
or    O
propyl    B-Aniline114754505
4-aminobenzoate    I-Aniline114754505
)    O
is    O
a    O
local    O
anesthetic    O
.    O

Drug    O
-    O
induced    O
QT    O
prolongation    O
is    O
usually    O
a    O
result    O
of    O
treatment    O
by    O
antiarrhythmic    O
drugs    O
such    O
as    O
amiodarone    O
and    O
sotalol    O
or    O
a    O
number    O
of    O
other    O
drugs    O
that    O
have    O
been    O
reported    O
to    O
cause    O
this    O
problem    O
(    O
e.g.    O
,    O
cisapride    B-Aniline114754505
)    O
.    O

Cisapride    B-Aniline114754505
(    O
gastroprokinetic    O
)    O

Cisapride    B-Aniline114754505
may    O
enhance    O
the    O
absorption    O
,    O
and    O
therefore    O
the    O
sedative    O
activity    O
,    O
of    O
diazepam    O
.    O

Drug    O
-    O
induced    O
QT    O
prolongation    O
is    O
seen    O
with    O
a    O
QT    O
interval    O
above    O
0.45    O
ms    O
on    O
the    O
ECG    O
and    O
is    O
usually    O
a    O
result    O
of    O
treatment    O
by    O
anti    O
-    O
arrhythmic    O
drugs    O
,    O
such    O
as    O
amiodarone    O
and    O
sotalol    O
,    O
or    O
a    O
number    O
of    O
other    O
drugs    O
that    O
have    O
been    O
reported    O
to    O
cause    O
this    O
problem    O
(    O
e.g.    O
,    O
cisapride    B-Aniline114754505
)    O
.    O

Cisapride    B-Aniline114754505

With    O
his    O
contribution    O
,    O
several    O
products    O
were    O
introduced    O
for    O
the    O
first    O
in    O
India    O
e.g.    O
Hydroxychloroquine    O
(    O
DMARD    O
)    O
,    O
Beta    O
-    O
Arteether    O
,    O
Aceclofenac    B-Aniline114754505
,    O
Norfloxacin    O
,    O
Combination    O
of    O
Atenolol    O
and    O
Nifedipine    O
,    O
Alprazolam    O
,    O
and    O
Midazolam    O
.    O

Aditoprim    B-Aniline114754505
is    O
an    O
antibacterial    O
dihydrofolate    O
reductase    O
inhibitor    O
.    O

"N,N,N′,N′"-tetramethyl-"p"-phenylenediamine    B-Aniline114754505
or    O
TMPD    O
,    O
used    O
in    O
microbiology    O

GBLD-345    B-Aniline114754505

"p"-phenylenediamine    B-Aniline114754505
or    O
PPD    O
,    O
a    O
chemical    O
compound    O
C6H4(NH2)2    O

It    O
is    O
isomeric    O
with    O
"m"-phenylenediamine    B-Aniline114754505
and    O
"p"-phenylenediamine    B-Aniline114754505
,    O
and    O
is    O
commonly    O
referred    O
to    O
as    O
OPD    O
.    O

It    O
is    O
an    O
isomer    O
of    O
"o"-phenylenediamine    B-Aniline114754505
and    O
"p"-phenylenediamine    B-Aniline114754505
.    O

Phenylenediamine    O
("'PPD    B-Aniline114754505
)    O
is    O
an    O
organic    O
compound    O
with    O
the    O
formula    O
C6H4(NH2)2    O
.    O

2006    O
–    O
"p"-Phenylenediamine    B-Aniline114754505
-    O
PPD    O
is    O
the    O
hair    O
dye    O
chemical    O
that    O
is    O
used    O
to    O
augment    O
black    O
henna    O
tattoos    O
.    O

Pendimethalin    B-Aniline114754505
is    O
an    O
herbicide    O
of    O
the    O
dinitroaniline    B-Aniline114754505
class    O
used    O
in    O
premergence    O
and    O
postemergence    O
applications    O
to    O
control    O
annual    O
grasses    O
and    O
certain    O
broadleaf    O
weeds    O
.    O

Solabegron    B-Aniline114754505
(    O
code    O
name    O
GW-427,353    B-Aniline114754505
)    O
is    O
a    O
drug    O
which    O
acts    O
as    O
a    O
selective    O
agonist    O
for    O
the    O
β3    O
adrenergic    O
receptor    O
.    O

His    O
successful    O
results    O
,    O
published    O
in    O
1941    O
,    O
convinced    O
Faget    O
to    O
begin    O
human    O
studies    O
,    O
both    O
with    O
promin    O
and    O
sulfoxone    B-Aniline114754505
sodium    O
,    O
a    O
related    O
compound    O
from    O
Abbott    O
Laboratories    O
.    O

A    O
wide    O
range    O
of    O
primary    O
,    O
secondary    O
and    O
tertiary    O
amines    O
can    O
act    O
as    O
acceptors    O
,    O
including    O
tryptamine    O
,    O
aniline    B-Aniline114754505
,    O
nicotine    O
and    O
a    O
variety    O
of    O
drugs    O
and    O
other    O
xenobiotics    O
.    O

Commercially    O
available    O
,    O
this    O
compound    O
may    O
be    O
synthesized    O
by    O
reacting    O
aniline    B-Aniline114754505
with    O
carbon    O
disulfide    O
and    O
concentrated    O
ammonia    O
to    O
give    O
the    O
ammonium    O
dithiocarbamate    O
salt    O
.    O

Another    O
method    O
of    O
synthesizing    O
this    O
reagent    O
involves    O
a    O
Sandmeyer    O
reaction    O
using    O
aniline    B-Aniline114754505
,    O
sodium    O
nitrite    O
and    O
copper(I    O
)    O
thiocyanate    O
.    O

He    O
partly    O
transformed    O
aniline    B-Aniline114754505
into    O
a    O
crude    O
mixture    O
which    O
,    O
when    O
extracted    O
with    O
alcohol    O
,    O
produced    O
a    O
substance    O
with    O
an    O
intense    O
purple    O
colour    O
.    O

The    O
Herz    O
reaction    O
,    O
named    O
after    O
the    O
chemist    O
Richard    O
Herz    O
,    O
is    O
the    O
chemical    O
conversion    O
of    O
an    O
aniline    B-Aniline114754505
-    O
derivative    O
(    O
1    O
)    O
to    O
a    O
so    O
-    O
called    O
Herz    O
salt    O
(    O
2    O
)    O
with    O
disulfur    O
dichloride    O
,    O
followed    O
by    O
hydrolysis    O
of    O
this    O
Herz    O
salt    O
(    O
2    O
)    O
to    O
the    O
corresponding    O
sodium    O
thiolate    O
(    O
3    O
)    O
:    O

In    O
contrast    O
to    O
the    O
three    O
species    O
of    O
"    O
Collybia    O
"    O
,    O
"    O
D.    O
racemosa    O
"    O
shows    O
negligible    O
reactivity    O
to    O
common    O
chemical    O
tests    O
used    O
in    O
mushroom    O
identification    O
,    O
including    O
aniline    B-Aniline114754505
,    O
alpha    O
-    O
napthol    O
,    O
guaiacol    O
,    O
sulfoformol    O
,    O
phenol    O
,    O
and    O
phenol    O
-    O
aniline    O
.    O

Aniline    B-Aniline114754505

Aniline    B-Aniline114754505
dyes    O
were    O
applied    O
to    O
a    O
black    O
-    O
and    O
-    O
white    O
print    O
using    O
gelatin    O
imbibition    O
matrices    O
.    O

Typical    O
antioxidants    O
are    O
derivatives    O
of    O
aniline    B-Aniline114754505
.    O

oxidation    O
of    O
aniline    B-Aniline114754505
with    O
lead    O
oxide    O

The    O
cause    O
of    O
the    O
blasts    O
was    O
initially    O
determined    O
two    O
days    O
after    O
the    O
blast    O
:    O
the    O
accident    O
site    O
is    O
a    O
nitration    O
unit    O
for    O
aniline    B-Aniline114754505
equipment    O
.    O

The    O
next    O
step    O
is    O
the    O
colouring    O
of    O
the    O
rice    O
,    O
in    O
the    O
various    O
colours    O
and    O
tones    O
needed    O
,    O
dipping    O
it    O
into    O
a    O
bath    O
of    O
aniline    B-Aniline114754505
,    O
acrylics    O
or    O
enamel    O
paintings    O
.    O

It    O
is    O
a    O
broad    O
class    O
of    O
compounds    O
that    O
encompasses    O
aniline    B-Aniline114754505
,    O
but    O
also    O
many    O
more    O
complex    O
aromatic    O
rings    O
and    O
many    O
amine    O
substituents    O
beyond    O
NH2    O
.    O

Notable    O
examples    O
include    O
:    O
scrotal    O
cancer    O
among    O
chimney    O
sweeps    O
in    O
18th    O
century    O
London    O
;    O
osteosarcoma    O
among    O
female    O
watch    O
dial    O
painters    O
in    O
the    O
20th    O
century    O
;    O
skin    O
cancer    O
in    O
farmers    O
;    O
bladder    O
cancer    O
in    O
dye    O
workers    O
exposed    O
to    O
aniline    B-Aniline114754505
compounds    O
;    O
and    O
leukemia    O
and    O
lymphoma    O
in    O
chemical    O
workers    O
exposed    O
to    O
benzene    O
.    O

At    O
first    O
the    O
production    O
of    O
dyes    O
based    O
on    O
aniline    B-Aniline114754505
was    O
critical    O
.    O

Nikolai    O
Zinin    O
,    O
discovered    O
benzidine    B-Aniline114754505
,    O
co    O
-    O
discovered    O
aniline    B-Aniline114754505
,    O
the    O
first    O
President    O
of    O
the    O
Russian    O
Physical    O
-    O
Chemical    O
Society    O

Malina    O
solved    O
the    O
problem    O
by    O
replacing    O
the    O
gasoline    O
with    O
aniline    B-Aniline114754505
,    O
resulting    O
in    O
a    O
successful    O
test    O
launch    O
of    O
a    O
JATO    O
-    O
equipped    O
A-20A    O
plane    O
at    O
the    O
Muroc    O
Auxiliary    O
Air    O
Field    O
in    O
the    O
Mojave    O
Desert    O
.    O

In    O
part    O
three    O
of    O
the    O
experiment    O
series    O
,    O
polar    O
narcotics    O
phenol    O
,    O
2,4-dimethylphenol    O
,    O
aniline    B-Aniline114754505
,    O
2-chloroaniline    O
and    O
4-chloroaniline    B-Aniline114754505
were    O
evaluated    O
.    O

Van    O
der    O
Waals    O
molecules    O
formed    O
with    O
organic    O
molecules    O
in    O
gas    O
include    O
aniline    B-Aniline114754505
,    O
dimethyl    O
ether    O
,    O
1,1-difluoroethylene    O
,    O
pyrimidine    O
,    O
chlorobenzene    O
,    O
cyclopentanone    O
,    O
cyanocyclobutane    O
,    O
and    O
cyclopentadienyl    O
.    O

Aniline    B-Aniline114754505
chemistry    O
;    O

It    O
is    O
an    O
intermediate    O
in    O
the    O
redox    O
-    O
related    O
pair    O
C6H5NH2    B-Aniline114754505
and    O
C6H5NO    O
.    O

In    O
Kingsport    O
,    O
Tennessee    O
,    O
an    O
explosion    O
at    O
the    O
aniline    B-Aniline114754505
plant    O
at    O
Eastman    O
Chemical    O
Company    O
,    O
killed    O
fifteen    O
employees    O
and    O
injured    O
more    O
than    O
200    O
.    O

Novosphingobium    O
is    O
a    O
genus    O
of    O
Gram    O
-    O
negative    O
bacteria    O
that    O
includes    O
"    O
N.    O
taihuense    O
"    O
,    O
which    O
can    O
degrade    O
aromatic    O
compounds    O
such    O
as    O
phenol    O
,    O
aniline    B-Aniline114754505
,    O
nitrobenzene    O
and    O
phenanthrene    O
.    O

This    O
derivative    O
of    O
aniline    B-Aniline114754505
is    O
a    O
white    O
solid    O
,    O
but    O
samples    O
can    O
darken    O
due    O
to    O
air    O
oxidation    O
.    O

Its    O
use    O
is    O
being    O
supplanted    O
by    O
other    O
aniline    B-Aniline114754505
analogues    O
and    O
derivatives    O
such    O
as    O
2,5-diamino(hydroxyethylbenzene    O
and    O
2,5-diaminotoluene    B-Aniline114754505
.    O

:    O
(    O
iv    O
)    O
by    O
substitution    O
in    O
the    O
aniline    B-Aniline114754505
ring    O
with    O
alkyl    O
,    O
alkoxy    O
,    O
alkylenedioxy    O
,    O
halogeno    O
or    O
haloalkyl    O
groups    O
;    O

Also    O
included    O
are    O
the    O
aromatic    O
nitro-    O
,    O
amino-    O
,    O
and    O
pyridilium    O
-    O
deratives    O
:    O
nitrobenzene    O
,    O
dinitrobenzene    O
,    O
trinitrotoluene    O
,    O
paramethylaminophenol    O
sulfate    O
(    O
Metol    O
)    O
,    O
dinitro    O
-    O
ortho    O
-    O
cresol    O
,    O
aniline    B-Aniline114754505
,    O
trinitrophenylmethylnitramine    O
(    O
tetryl    O
)    O
,    O
hexanitrodiphenylamine    B-Aniline114754505
(    O
aurantia    O
)    O
,    O
phenylenediamines    O
,    O
and    O
paraquat    O
.    O

The    O
Knorr    O
quinoline    O
synthesis    O
is    O
an    O
intramolecular    O
organic    O
reaction    O
converting    O
a    O
β-ketoanilide    B-Aniline114754505
to    O
a    O
2-hydroxyquinoline    O
using    O
sulfuric    O
acid    O
.    O

A    O
reaction    O
mechanism    O
identified    O
a    O
N    O
,    O
O    O
-    O
dicationic    O
intermediate    O
A    O
with    O
excess    O
acid    O
capable    O
of    O
ring    O
-    O
closing    O
and    O
a    O
monocationic    O
intermediate    O
B    O
which    O
fragments    O
to    O
aniline    B-Aniline114754505
and    O
(    O
ultimately    O
to    O
)    O
acetophenone    O
.    O

Nilotinib    O
binds    O
to    O
the    O
kinase    O
domain    O
by    O
making    O
four    O
hydrogen    O
bond    O
interactions    O
involving    O
the    O
pyridyl    O
-    O
N    O
and    O
the    O
backbone    O
NH    O
of    O
Met-318    O
,    O
the    O
anilino    B-Aniline114754505
-    O
NH    O
and    O
the    O
side    O
chain    O
OH    O
of    O
Thr-315    O
,    O
the    O
amido    O
-    O
NH    O
and    O
side    O
chain    O
carboxylate    O
of    O
Glu-286    O
and    O
the    O
amido    O
carbonyl    O
with    O
the    O
backbone    O
NH    O
of    O
the    O
Asp-381    O
.    O

In    O
a    O
video    O
interview    O
in    O
2002    O
,    O
he    O
explained    O
that    O
his    O
cancer    O
was    O
caused    O
by    O
the    O
toxicity    O
of    O
the    O
aniline    B-Aniline114754505
dyes    O
he    O
had    O
used    O
to    O
paint    O
directly    O
onto    O
film    O
.    O

The    O
artists    O
paint    O
the    O
figures    O
with    O
aniline    B-Aniline114754505
dyes    O
with    O
motifs    O
of    O
brightly    O
colored    O
strips    O
and    O
spots    O
.    O

The    O
corresponding    O
aniline    B-Aniline114754505
or    O
aryl    O
amide    O
reaction    O
is    O
sometimes    O
called    O
Goldberg    O
reaction    O
,    O
named    O
after    O
Irma    O
Goldberg    O
.    O

For    O
aryl    O
amines    O
,    O
nitrobenzenes    O
are    O
converted    O
to    O
aniline    B-Aniline114754505
,    O
and    O
azoxybenzenes    O
to    O
azobenzenes    O
.    O

A    O
positive    O
reaction    O
of    O
Schaeffer    O
's    O
test    O
,    O
which    O
uses    O
the    O
reaction    O
of    O
aniline    B-Aniline114754505
and    O
nitric    O
acid    O
on    O
the    O
surface    O
of    O
the    O
mushroom    O
,    O
is    O
indicated    O
by    O
an    O
orange    O
to    O
red    O
color    O
;    O
it    O
is    O
characteristic    O
of    O
species    O
in    O
the    O
section    O
"    O
Flavescentes    O
"    O
.    O

It    O
is    O
insoluble    O
in    O
nitric    O
acid    O
,    O
but    O
dissolves    O
in    O
ammonia    O
,    O
alkali    O
chlorides    O
,    O
alkali    O
cyanides    O
,    O
aniline    B-Aniline114754505
,    O
pyridine    O
,    O
and    O
potassium    O
iodide    O
by    O
forming    O
complexes    O
.    O

Borderline    O
bases    O
are    O
:    O
aniline    B-Aniline114754505
,    O
pyridine    O
,    O
nitrogen    O
N2    O
and    O
the    O
azide    O
,    O
chloride    O
,    O
bromide    O
,    O
nitrate    O
and    O
sulfate    O
anions    O
.    O

Important    O
amines    O
include    O
amino    O
acids    O
,    O
biogenic    O
amines    O
,    O
trimethylamine    O
,    O
and    O
aniline    B-Aniline114754505
;    O
see    O
for    O
a    O
list    O
of    O
amines    O
.    O

Aromatic    O
amines    O
have    O
the    O
nitrogen    O
atom    O
connected    O
to    O
an    O
aromatic    O
ring    O
as    O
in    O
the    O
various    O
aniline    B-Aniline114754505
.    O

Important    O
primary    O
alkyl    O
amines    O
include    O
,    O
methylamine    O
,    O
most    O
amino    O
acids    O
,    O
and    O
the    O
buffering    O
agent    O
tris    O
,    O
while    O
primary    O
aromatic    O
amines    O
include    O
aniline    B-Aniline114754505
.    O

Aromatic    O
amines    O
,    O
such    O
as    O
aniline    B-Aniline114754505
,    O
have    O
their    O
lone    O
pair    O
electrons    O
conjugated    O
into    O
the    O
benzene    O
ring    O
,    O
thus    O
their    O
tendency    O
to    O
engage    O
in    O
hydrogen    O
bonding    O
is    O
diminished    O
.    O

Aniline    B-Aniline114754505
(    O
C6H5NH2    O
)    O
and    O
its    O
derivatives    O
are    O
prepared    O
by    O
reduction    O
of    O
the    O
nitroaromatics    O
.    O

The    O
most    O
important    O
members    O
are    O
derivatives    O
of    O
aromatic    O
amines    O
such    O
as    O
aniline    B-Aniline114754505
(    O
"    O
phenylamine    O
"    O
)    O
(    O
A    O
=    O
aryl    O
or    O
naphthyl    O
)    O
:    O

He    O
obtained    O
further    O
evidence    O
for    O
the    O
formation    O
of    O
tetraphenylmethane    O
by    O
reducing    O
the    O
nitro    O
groups    O
to    O
amino    O
groups    O
with    O
zinc    O
dust    O
in    O
acetic    O
acid    O
to    O
the    O
leuco    O
dye    O
7    O
which    O
on    O
exposure    O
to    O
hydrochloric    O
acid    O
eliminates    O
aniline    B-Aniline114754505
to    O
the    O
known    O
compound    O
pararosanilin    B-Aniline114754505
8    O
.    O

aniline    B-Aniline114754505

Teaching    O
materials    O
for    O
students    O
included    O
a    O
notebook    O
made    O
of    O
sewn    O
office    O
paper    O
,    O
ink    O
made    O
with    O
blue    O
aniline    B-Aniline114754505
.    O

Bloede    O
's    O
familiarity    O
with    O
the    O
textile    O
industry    O
led    O
to    O
the    O
idea    O
of    O
manufacturing    O
aniline    B-Aniline114754505
dyes    O
to    O
increase    O
profits    O
.    O

A    O
new    O
class    O
of    O
COFs    O
can    O
be    O
obtained    O
by    O
imine    O
condensation    O
of    O
aniline    B-Aniline114754505
with    O
benzaldehyde    O
that    O
results    O
in    O
imine    O
bond    O
formation    O
with    O
elimination    O
of    O
water    O
.    O

In    O
1826    O
at    O
the    O
age    O
of    O
20    O
,    O
Unverdorben    O
discovered    O
aniline    B-Aniline114754505
,    O
which    O
he    O
obtained    O
from    O
the    O
distillation    O
of    O
natural    O
vegetable    O
indigo    O
.    O

Dimethyl    O
carbonate    O
methylates    O
aniline    B-Aniline114754505
,    O
phenols    O
and    O
carboxylic    O
acids    O
,    O
but    O
many    O
of    O
these    O
reactions    O
require    O
the    O
use    O
of    O
an    O
autoclave    O
.    O

It    O
can    O
be    O
prepared    O
from    O
aniline    B-Aniline114754505
and    O
paraldehyde    O
via    O
Skraup    O
synthesis    O
or    O
from    O
aniline    O
and    O
crotonaldehyde    O
via    O
Doebner    O
-    O
von    O
Miller    O
variation    O
of    O
the    O
Skraup    O
reaction    O
.    O

The    O
study    O
of    O
organic    O
nitrogen    O
bases    O
led    O
to    O
his    O
attempt    O
to    O
solve    O
the    O
difficult    O
problem    O
of    O
the    O
constitution    O
and    O
transformations    O
of    O
the    O
aldol    O
bases    O
derived    O
from    O
the    O
homologues    O
of    O
aniline    B-Aniline114754505
.    O

Oryzalin    B-Aniline114754505
is    O
an    O
herbicide    O
of    O
the    O
dinitroaniline    B-Aniline114754505
class    O
.    O

Palmer    O
amaranth    O
is    O
among    O
the    O
"    O
top    O
five    O
most    O
troublesome    O
weeds    O
"    O
in    O
the    O
southeast    O
of    O
the    O
United    O
States    O
and    O
has    O
already    O
evolved    O
resistances    O
to    O
dinitroaniline    B-Aniline114754505
herbicides    O
and    O
acetolactate    O
synthase    O
inhibitors    O
.    O

Solvent    B-Aniline114754505
Violet    I-Aniline114754505
13    I-Aniline114754505

4,4'-Methylenedianiline    B-Aniline114754505
(    O
MDA    B-Aniline114754505
)    O
is    O
an    O
organic    O
compound    O
]    O
]    O
with    O
the    O
formula    O
CH2(C6H4NH2)2    O
.    O

The    O
compound    O
may    O
be    O
used    O
in    O
combination    O
with    O
other    O
herbicides    O
such    O
as    O
atrazine    O
,    O
2,4-D    O
,    O
bromacil    O
,    O
diuron    B-Aniline114754505
,    O
and    O
sodium    O
metaborate    O
.    O

The    O
products    O
which    O
have    O
replaced    O
them    O
for    O
small    O
boats    O
(    O
e.g.    O
Diuron    B-Aniline114754505
and    O
Irgarol    O
)    O
pose    O
similar    O
problems    O
and    O
have    O
been    O
measured    O
in    O
non    O
-    O
negligible    O
quantities    O
in    O
the    O
roadstead    O
by    O
Ifremer    O
in    O
2003    O
-    O
2004    O
.    O

4-Chloro-"o"-toluidine    B-Aniline114754505
(    O
4-COT    B-Aniline114754505
,    O
4-chloro-2-methylaniline    B-Aniline114754505
)    O
is    O
the    O
organic    O
compound    O
with    O
the    O
formula    O
CH3C6H3Cl(NH2    O
)    O
.    O

Alminoprofen    B-Aniline114754505
is    O
a    O
non    O
-    O
steroidal    O
anti    O
-    O
inflammatory    O
drug    O
.    O

Amine    O
-    O
ester    O
ineterchange    O
of    O
that    O
compound    O
with    O
N-methylaniline    B-Aniline114754505
results    O
in    O
formation    O
of    O
the    O
amide    O
roquinimex    O
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
4-nitrophenyl-3-ketovalidamine    O
,    O
and    O
two    O
products    O
,    O
4-nitroaniline    B-Aniline114754505
and    O
5-D-(5/6)-5-C-(hydroxymethyl)-2,6-dihydroxycyclohex-2-en-1-one    O
.    O

Most    O
commonly    O
,    O
4-nitrochlorobenzene    O
is    O
treated    O
with    O
ammonia    O
and    O
the    O
resulting    O
4-nitroaniline    B-Aniline114754505
is    O
then    O
hydrogenated    O
:    O

File    O
:    O
Pararosaniline    B-Aniline114754505

He    O
obtained    O
further    O
evidence    O
for    O
the    O
formation    O
of    O
tetraphenylmethane    O
by    O
reducing    O
the    O
nitro    O
groups    O
to    O
amino    O
groups    O
with    O
zinc    O
dust    O
in    O
acetic    O
acid    O
to    O
the    O
leuco    O
dye    O
7    O
which    O
on    O
exposure    O
to    O
hydrochloric    O
acid    O
eliminates    O
aniline    B-Aniline114754505
to    O
the    O
known    O
compound    O
pararosanilin    B-Aniline114754505
8    O
.    O

Its    O
use    O
is    O
being    O
supplanted    O
by    O
other    O
aniline    B-Aniline114754505
analogues    O
and    O
derivatives    O
such    O
as    O
2,5-diamino(hydroxyethylbenzene    O
and    O
2,5-diaminotoluene    B-Aniline114754505
.    O

Cambia    O
,    O
a    O
trade    O
name    O
for    O
the    O
anti    O
-    O
inflammatory    O
drug    O
diclofenac    B-Aniline114754505

Diclofenac    B-Aniline114754505
sodium    O
:    O
Nonsteroidal    O
anti    O
-    O
inflammatory    O
drug    O
(    O
NSAID    O
)    O
with    O
analgesic    O
properties    O

Kaziranga    O
was    O
once    O
home    O
to    O
seven    O
species    O
of    O
vultures    O
,    O
but    O
the    O
vulture    O
population    O
reached    O
near    O
extinction    O
,    O
supposedly    O
by    O
feeding    O
on    O
animal    O
carcasses    O
containing    O
the    O
drug    O
Diclofenac    B-Aniline114754505
.    O

Another    O
theoretical    O
interaction    O
is    O
with    O
drugs    O
with    O
affinity    O
to    O
the    O
transporter    O
protein    O
ABCG2    O
(    O
also    O
known    O
as    O
BCRP    O
)    O
,    O
such    O
as    O
pitavastatin    O
,    O
pravastatin    O
,    O
ciprofloxacin    O
,    O
methotrexat    O
,    O
and    O
diclofenac    B-Aniline114754505
;    O
a    O
study    O
with    O
the    O
latter    O
has    O
shown    O
no    O
clinical    O
relevance    O
.    O

A    O
methanol    O
extract    O
of    O
"    O
P.    O
pulmonarius    O
"    O
displayed    O
anti    O
-    O
inflammatory    O
and    O
antitumor    O
activity    O
comparable    O
to    O
the    O
standard    O
reference    O
drugs    O
diclofenac    B-Aniline114754505
and    O
cisplatin    O
,    O
respectively    O
.    O

Bearers    O
of    O
this    O
SNP    O
may    O
or    O
may    O
not    O
show    O
increased    O
risk    O
of    O
developing    O
acute    O
gastrointestinal    O
bleeding    O
during    O
the    O
use    O
of    O
non    O
-    O
steroidal    O
anti    O
-    O
inflammatory    O
drugs    O
(    O
NSAIDs    O
)    O
that    O
are    O
its    O
substrates    O
such    O
as    O
aceclofenac    B-Aniline114754505
,    O
celecoxib    O
,    O
diclofenac    B-Aniline114754505
,    O
ibuprofen    O
,    O
indomethacin    O
,    O
lornoxicam    O
,    O
meloxicam    O
,    O
naproxen    O
,    O
piroxicam    O
,    O
tenoxicam    O
,    O
and    O
valdecoxib    O
.    O

Pain    O
may    O
be    O
treated    O
with    O
anti    O
-    O
inflammatories    O
,    O
NSAIDs    O
such    O
as    O
ketorolac    O
or    O
diclofenac    B-Aniline114754505
.    O

In    O
the    O
CLASS    O
trial    O
comparing    O
Celebrex    O
800    O
mg    O
/    O
day    O
to    O
ibuprofen    O
2400    O
mg    O
/    O
day    O
and    O
diclofenac    B-Aniline114754505
150    O
mg    O
/    O
day    O
for    O
osteoarthritis    O
or    O
rheumatoid    O
arthritis    O
for    O
six    O
months    O
,    O
Celebrex    O
was    O
associated    O
with    O
significantly    O
fewer    O
upper    O
gastrointestinal    O
complications    O
(    O
0.44%    O
vs.    O
1.27%    O
,    O
P=0.04    O
)    O
,    O
with    O
no    O
significant    O
difference    O
in    O
incidence    O
of    O
cardiovascular    O
events    O
in    O
patients    O
not    O
taking    O
aspirin    O
for    O
cardiovascular    O
prophylaxis    O
.    O

The    O
NSAID    O
diclofenac    B-Aniline114754505
has    O
an    O
antiuricosuric    O
action    O
,    O
which    O
may    O
be    O
partly    O
responsible    O
for    O
the    O
extraordinary    O
toxicity    O
of    O
this    O
drug    O
in    O
vultures    O
.    O

In    O
southern    O
Asia    O
,    O
vultures    O
that    O
consumed    O
carcasses    O
of    O
livestock    O
declined    O
95%    O
due    O
to    O
their    O
ingestion    O
of    O
the    O
antibiotic    O
known    O
as    O
diclofenac    B-Aniline114754505
.    O

These    O
include    O
the    O
Asian    O
elephant    O
,    O
the    O
Asiatic    O
lion    O
,    O
Bengal    O
tiger    O
,    O
Indian    O
rhinoceros    O
,    O
mugger    O
crocodile    O
,    O
and    O
Indian    O
white    O
-    O
rumped    O
vulture    O
,    O
which    O
suffered    O
a    O
near    O
-    O
extinction    O
from    O
ingesting    O
the    O
carrion    O
of    O
diclofenac    B-Aniline114754505
-    O
treated    O
cattle    O
.    O

This    O
makes    O
aspirin    O
different    O
from    O
other    O
NSAIDs    O
(    O
such    O
as    O
diclofenac    B-Aniline114754505
and    O
ibuprofen    O
)    O
,    O
which    O
are    O
reversible    O
inhibitors    O
.    O

Painful    O
joints    O
,    O
for    O
example    O
,    O
may    O
be    O
treated    O
with    O
an    O
ibuprofen-    O
or    O
diclofenac    B-Aniline114754505
-    O
containing    O
gel    O
(    O
The    O
labeling    O
for    O
topical    O
diclofenac    O
has    O
been    O
updated    O
to    O
warn    O
about    O
drug    O
-    O
induced    O
hepatotoxicity    O
.    O
)    O
;    O
capsaicin    O
also    O
is    O
used    O
topically    O
.    O

Peregrine    O
Fund    O
research    O
published    O
in    O
the    O
journal    O
"    O
Nature    O
"    O
determined    O
that    O
poisoning    O
from    O
the    O
residues    O
of    O
diclofenac    B-Aniline114754505
in    O
the    O
carcasses    O
of    O
livestock    O
that    O
had    O
been    O
treated    O
with    O
the    O
drug    O
for    O
veterinary    O
purposes    O
was    O
responsible    O
for    O
the    O
catastrophic    O
die    O
-    O
off    O
.    O

It    O
is    O
also    O
used    O
in    O
penicillin    O
G    O
production    O
and    O
diclofenac    B-Aniline114754505
production    O
.    O

Ethylhexyl    B-Aniline114754505
triazone    I-Aniline114754505
(    O
Uvinul    O
T    O
150    O
)    O

Brifentanil    B-Aniline114754505

dabigatran    B-Aniline114754505
(    O
USAN    O
)    O

Dabigatran    B-Aniline114754505
vs.    O
warfarin    O
for    O
stroke    O
prevention    O
with    O
non    O
-    O
valvular    O
atrial    O
fibrillation    O
(    O
English    O
)    O

Other    O
drugs    O
with    O
adverse    O
reactions    O
include    O
adefovir    O
,    O
dabigatran    B-Aniline114754505
etexilate    I-Aniline114754505
,    O
lamivudine    O
,    O
and    O
vincristine    O
.    O

These    O
direct    O
Factor    O
Xa    O
inhibitors    O
can    O
be    O
administered    O
orally    O
,    O
as    O
can    O
dabigatran    B-Aniline114754505
etexilate    I-Aniline114754505
which    O
is    O
a    O
direct    O
thrombin    O
inhibitor    O
.    O

In    O
September    O
2013    O
,    O
the    O
FDA    O
announced    O
that    O
Zoetis    O
and    O
Fleming    O
Laboratories    O
would    O
voluntarily    O
withdraw    O
current    O
roxarsone    O
,    O
arsanilic    B-Aniline114754505
acid    I-Aniline114754505
,    O
and    O
carbarsone    B-Aniline114754505
approvals    O
,    O
leaving    O
only    O
nitarsone    O
approvals    O
in    O
place    O
.    O

Menthyl    B-Aniline114754505
anthranilate    I-Aniline114754505
(    O
meradimate    B-Aniline114754505
)    O
is    O
a    O
sunscreening    O
agent    O
.    O

Binding    O
of    O
the    O
antibody    O
is    O
often    O
inferred    O
from    O
the    O
color    O
change    O
of    O
reagents    O
such    O
as    O
TMB    B-Aniline114754505
.    O

An    O
example    O
is    O
Disperse    B-Aniline114754505
Orange    I-Aniline114754505
1    I-Aniline114754505
.    O

2,6-Xylidine    B-Aniline114754505
is    O
an    O
organic    O
compound    O
with    O
the    O
formula    O
C6H3(CH3)2NH2    O
.    O

Trifluralin    B-Aniline114754505
was    O
widely    O
used    O
in    O
the    O
20th    O
century    O
,    O
for    O
example    O
,    O
in    O
over    O
half    O
of    O
U.S.    O
cotton    O
field    O
acreage    O
in    O
1998    O
.    O
)    O

Preen    O
,    O
a    O
trade    O
name    O
for    O
trifluralin    B-Aniline114754505

nicarbazin    B-Aniline114754505

Nicarbazin    B-Aniline114754505
is    O
a    O
coccidiostat    O
used    O
on    O
meat    O
chickens    O
.    O

Phenylhydroxylamine    B-Aniline114754505
is    O
the    O
organic    O
compound    O
with    O
the    O
formula    O
C6H5NHOH    O
.    O

Cupferron    O
is    O
prepared    O
from    O
phenylhydroxylamine    B-Aniline114754505
and    O
an    O
NO+    O
source    O
:    O

PAH    O
(    O
"para"-aminohippurate    B-Aniline114754505
)    O
is    O
freely    O
filtered    O
,    O
is    O
not    O
reabsorbed    O
,    O
and    O
is    O
secreted    O
within    O
the    O
nephron    O
.    O

When    O
using    O
a    O
compound    O
with    O
an    O
extraction    O
ratio    O
near    O
1    O
,    O
such    O
as    O
para-aminohippurate    B-Aniline114754505
(    O
PAH    O
)    O
,    O
eRPF    O
approximates    O
RPF    O
.    O

Dimethocaine/Larocaine    B-Aniline114754505
(DMC)    I-Aniline114754505
(    O
An    O
aniline    O
)    O

Dimethocaine    B-Aniline114754505
(    O
Larocaine    B-Aniline114754505
)    O
is    O
a    O
local    O
anesthetic    O
with    O
stimulant    O
properties    O
that    O
some    O
studies    O
have    O
shown    O
to    O
be    O
half    O
the    O
potency    O
of    O
cocaine    O
.    O

First    O
generation    O
drugs    O
include    O
acetohexamide    O
,    O
carbutamide    B-Aniline114754505
,    O
chlorpropamide    O
,    O
glycyclamide    O
(    O
tolhexamide    O
)    O
,    O
metahexamide    O
,    O
tolazamide    O
and    O
tolbutamide    O
.    O

Batanopride    B-Aniline114754505
(    O
INN    O
)    O

Chrysoine    B-Aniline114754505
resorcinol    I-Aniline114754505
(    O
azo    O
coupling    O
with    O
resorcinol    O
)    O

File    O
:    O
Victoria    O
blue    O
Victoria    B-Aniline114754505
blue    I-Aniline114754505
BO    I-Aniline114754505

Other    O
tests    O
for    O
detecting    O
amniotic    O
fluid    O
mainly    O
include    O
nitrazine    B-Aniline114754505
paper    O
test    O
and    O
fern    O
test    O
.    O

Piminodine    B-Aniline114754505
,    O
an    O
analgesic    O

Piminodine    B-Aniline114754505
(    O
Alvodine    B-Aniline114754505
)    O
is    O
an    O
opioid    O
analgesic    O
that    O
is    O
an    O
analogue    O
of    O
pethidine    O
(    O
meperidine    O
)    O
.    O

It    O
is    O
an    O
azo    O
dye    O
derived    O
from    O
dimethylaniline    B-Aniline114754505
.    O

He    O
developed    O
improved    O
methods    O
for    O
manufacture    O
of    O
ammonium    O
nitrate    O
,    O
extraction    O
of    O
tetryl    O
from    O
dimethylaniline    B-Aniline114754505
,    O
picric    O
acid    O
from    O
chlorobenzene    O
,    O
and    O
for    O
chlorinating    O
benzene    O
.    O

Dimethylaniline    B-Aniline114754505
,    O
a    O
chemical    O
used    O
for    O
curing    O
polyester    O
and    O
vinyl    O
ester    O
resins    O

A    O
glyoxylate    O
compound    O
has    O
been    O
added    O
to    O
N,N-dimethylaniline    B-Aniline114754505
with    O
a    O
chiral    O
bisoxazoline    O
ligand–    O

In    O
Europe    O
,    O
the    O
trade    O
name    O
is    O
Yellox    B-Aniline114754505
.    O

The    O
following    O
therapeutic    O
drugs    O
were    O
withdrawn    O
from    O
the    O
market    O
primarily    O
because    O
of    O
hepatotoxicity    O
:    O
Troglitazone    O
,    O
bromfenac    B-Aniline114754505
,    O
trovafloxacin    O
,    O
ebrotidine    O
,    O
nimesulide    O
,    O
nefazodone    O
,    O
ximelagatran    O
and    O
pemoline    O
.    O

Diaminobenzidine    B-Aniline114754505
stains    O
keratocytes    O
in    O
the    O
cross    O
-    O
section    O
of    O
cornea    O
.    O

The    O
second    O
generation    O
EGFR    O
inhibitor    O
Afatinib    O
has    O
been    O
approved    O
for    O
the    O
treatment    O
of    O
EGFR    O
driven    O
lung    O
cancer    O
and    O
Dacomitinib    B-Aniline114754505
is    O
in    O
late    O
stage    O
clinical    O
testing    O
.    O

For    O
example    O
,    O
"    O
p    O
"-    O
bromobiphenyl    O
may    O
be    O
prepared    O
from    O
4-bromoaniline    B-Aniline114754505
and    O
benzene    O
:    O

A    O
mixture    O
of    O
4,4'-oxydianiline    B-Aniline114754505
1    O
(    O
1.00    O
g    O
,    O
5.00    O
mmol    O
)    O
and    O
"    O
o    O
"-    O
vanillin    O
2    O
(    O
1.52    O
g    O
,    O
10.0    O
mmol    O
)    O
in    O
methanol    O
(    O
40.0    O
mL    O
)    O
is    O
stirred    O
at    O
room    O
temperature    O
for    O
one    O
hour    O
to    O
give    O
an    O
orange    O
precipitate    O
and    O
after    O
filtration    O
and    O
washing    O
with    O
methanol    O
to    O
give    O
the    O
pure    O
Schiff    O
base    O
3    O
(    O
2.27    O
g    O
,    O
97%    O
)    O
.    O

:    O
Light    O
green    O
SF    O
yellowish    O
,    O
Fast    B-Aniline114754505
Green    I-Aniline114754505
FCF    I-Aniline114754505
,    O
methyl    O
blue    O
,    O
water    B-Aniline114754505
blue    I-Aniline114754505

P-Dimethylaminocinnamaldehyde    B-Aniline114754505

The    O
DMACA    B-Aniline114754505
reagent    I-Aniline114754505
is    O
an    O
histological    O
dye    O
specific    O
to    O
polyphenols    O
used    O
in    O
microscopy    O
analyses    O
.    O

This    O
makes    O
it    O
a    O
useful    O
target    O
for    O
sulfonamide    O
antibiotics    O
,    O
which    O
compete    O
with    O
the    O
PABA    B-Aniline114754505
precursor    O
.    O

The    O
emollient    O
salicylic    O
acid    O
is    O
structurally    O
similar    O
to    O
para-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
(    O
PABA    O
)    O
,    O
commonly    O
found    O
in    O
sunscreen    O
,    O
and    O
is    O
known    O
to    O
interfere    O
with    O
phototherapy    O
in    O
psoriasis    O
.    O

Amino    O
esters    O
,    O
in    O
reference    O
to    O
anesthetic    O
agents    O
,    O
are    O
rapidly    O
metabolized    O
in    O
the    O
plasma    O
by    O
butyrlcholinesterase    O
to    O
para-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
derivatives    O
,    O
then    O
excreted    O
in    O
the    O
urine    O
.    O

Benzocaine    O
is    O
the    O
ethyl    O
ester    O
of    O
"p"-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
(    O
PABA    O
)    O
.    O

Benzocaine    O
can    O
be    O
prepared    O
by    O
esterification    O
using    O
4-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
and    O
ethanol    O
.    O

Also    O
,    O
"    O
Desulfobulbus    O
propionicus    O
"    O
strains    O
1pr3    O
T    O
and    O
3pr10    O
can    O
only    O
grow    O
in    O
defined    O
minimal    O
media    O
with    O
the    O
addition    O
of    O
a    O
vitamin    O
4-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
,    O
whereas    O
strain    O
2pr4    O
does    O
not    O
show    O
this    O
additional    O
requirement    O
.    O

#    O
Alteration    O
of    O
metabolic    O
pathway    O
:    O
for    O
example    O
,    O
some    O
sulfonamide    O
-    O
resistant    O
bacteria    O
do    O
not    O
require    O
para-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
(    O
PABA    O
)    O
,    O
an    O
important    O
precursor    O
for    O
the    O
synthesis    O
of    O
folic    O
acid    O
and    O
nucleic    O
acids    O
in    O
bacteria    O
inhibited    O
by    O
sulfonamides    O
,    O
instead    O
,    O
like    O
mammalian    O
cells    O
,    O
they    O
turn    O
to    O
using    O
preformed    O
folic    O
acid    O
.    O

Following    O
her    O
work    O
in    O
1942    O
with    O
David    O
E.    O
Green    O
on    O
amino-    O
and    O
hydroxy    O
acid    O
oxidases    O
,    O
and    O
on    O
a    O
peptide    O
form    O
of    O
p-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
,    O
she    O
became    O
interested    O
in    O
new    O
aspects    O
of    O
nitrogen    O
metabolism    O
.    O

It    O
is    O
a    O
precursor    O
to    O
3-aminobenzoic    B-Aniline114754505
acid    I-Aniline114754505
,    O
which    O
is    O
used    O
to    O
prepare    O
some    O
dyes    O
.    O

GYKI-52895    B-Aniline114754505
,    O
structural    O
benzodiazepine    O
which    O
is    O
a    O
dopamine    O
reuptake    O
inhibitor    O
without    O
GABAergic    O
function    O

Besides    O
the    O
NG    O
and    O
NC    O
,    O
M28    O
contains    O
2-nitrodiphenylamine    B-Aniline114754505
(    O
NDPA    O
)    O
as    O
a    O
stabilizer    O
.    O

Methyl    B-Aniline114754505
yellow    I-Aniline114754505
,    O
or    O
C.I.    B-Aniline114754505
11020    I-Aniline114754505
,    O
is    O
a    O
organic    O
compound    O
with    O
the    O
formula    O
C6H5N2C6H4N(CH3)2    O
.    O

amiflamine    B-Aniline114754505
(    O
INN    O
)    O

In    O
response    O
to    O
the    O
allegations    O
,    O
Kincannon    O
claimed    O
his    O
behavior    O
was    O
a    O
side    O
effect    O
of    O
benzonatate    B-Aniline114754505
,    O
which    O
he    O
was    O
prescribed    O
for    O
an    O
upper    O
respiratory    O
infection    O
.    O

Examples    O
of    O
drugs    O
made    O
from    O
PHBA    O
include    O
:    O
1    O
)    O
Nifuroxazide    O
,    O
2    O
)    O
Orthocaine    B-Aniline114754505
,    O
3    O
)    O
Ormeloxifene    O
&    O
4    O
)    O
Proxymetacaine    B-Aniline114754505
.    O

Dazopride    B-Aniline114754505

Padimate    B-Aniline114754505
A    I-Aniline114754505
(    O
Escalol    O
506    O
)    O

Propoxycaine    B-Aniline114754505

Julolidine    B-Aniline114754505

Torsemide    B-Aniline114754505

For    O
nonresponders    O
,    O
a    O
loop    O
diuretic    O
may    O
also    O
be    O
added    O
and    O
generally    O
,    O
furosemide    O
is    O
added    O
at    O
a    O
dose    O
of    O
40    O
mg    O
/    O
day    O
(    O
max    O
160    O
mg    O
/    O
day    O
)    O
,    O
or    O
alternatively    O
(    O
bumetanide    O
or    O
torasemide    B-Aniline114754505
)    O
.    O

In    O
the    O
laboratory    O
,    O
the    O
reduction    O
of    O
the    O
nitroaniline    B-Aniline114754505
is    O
effected    O
with    O
zinc    O
powder    O
in    O
ethanol    O
,    O
followed    O
by    O
purification    O
of    O
the    O
diamine    O
as    O
the    O
hydrochloride    O
salt    O
.    O

In    O
the    O
first    O
step    O
,    O
o-nitroaniline    B-Aniline114754505
(    O
compound    O
1    O
)    O
is    O
purified    O
through    O
dissolution    O
in    O
hot    O
water    O
-    O
ethanol    O
mixture    O
in    O
relation    O
2:1    O
.    O

Eventually    O
he    O
was    O
able    O
to    O
get    O
most    O
of    O
the    O
same    O
qualities    O
he    O
preferred    O
with    O
Kodak    O
's    O
Azo    O
glossy    O
silver    O
gelatin    O
paper    O
developed    O
in    O
Amidol    B-Aniline114754505
.    O

4-Aminobiphenyl    B-Aniline114754505

In    O
2004    O
a    O
known    O
human    O
carcinogen    O
,    O
4-aminobiphenyl    B-Aniline114754505
or    O
4-ABP    O
,    O
was    O
found    O
in    O
some    O
commercial    O
hair    O
dyes    O
.    O

The    O
thermochromic    O
droplets    O
are    O
actually    O
a    O
mixture    O
of    O
several    O
chemicals    O
—    O
crystal    B-Aniline114754505
violet    I-Aniline114754505
lactone    I-Aniline114754505
(    O
the    O
color    O
-    O
changing    O
dye    O
itself    O
)    O
,    O
benzotriazole    O
(    O
a    O
weak    O
acid    O
)    O
,    O
and    O
a    O
quaternary    O
ammonium    O
salt    O
of    O
a    O
fatty    O
acid    O
(    O
myristylammonium    O
oleate    O
)    O
dissolved    O
in    O
1-dodecanol    O
as    O
solvent    O
.    O

2,4,6-Trinitroaniline    B-Aniline114754505
,    O
a    O
nitrated    O
amine    O

Diphenylamine    B-Aniline114754505
,    O
a    O
chemical    O
stabiliser    O
used    O
in    O
homogeneous    O
propellants    O
to    O
absorb    O
the    O
catalyst    O
produced    O
by    O
the    O
autocatalytic    O
decomposition    O
of    O
propellants    O

Following    O
this    O
,    O
crude    O
tyramine    O
was    O
procured    O
by    O
heating    O
tyrosine    O
in    O
the    O
presence    O
of    O
the    O
catalyst    O
diphenylamine    B-Aniline114754505
.    O

Illustrated    O
is    O
the    O
reduction    O
of    O
phenothiazine    O
to    O
diphenylamine    B-Aniline114754505
:    O

Important    O
representatives    O
include    O
dimethylamine    O
,    O
while    O
an    O
example    O
of    O
an    O
aromatic    O
amine    O
would    O
be    O
diphenylamine    B-Aniline114754505
.    O

The    O
dye    O
Ethyl    B-Aniline114754505
Green    I-Aniline114754505
(    O
C.I.    B-Aniline114754505
42590    I-Aniline114754505
;    O
C27H35N3ClBr    O
is    O
a    O
triarylmethane    O
dye    O
.    O

In    O
a    O
2013    O
meta    O
-    O
analysis    O
of    O
the    O
efficacy    O
and    O
tolerability    O
of    O
15    O
antipsychotic    O
drugs    O
it    O
was    O
found    O
to    O
produce    O
the    O
second    O
least    O
(    O
after    O
haloperidol    O
)    O
weight    O
gain    O
,    O
the    O
least    O
QT    O
interval    O
prolongation    O
,    O
the    O
fourth    O
"    O
most    O
"    O
extrapyramidal    O
side    O
effects    O
(    O
after    O
haloperidol    O
,    O
zotepine    O
and    O
chlorpromazine    O
)    O
and    O
the    O
sixth    O
least    O
sedation    O
(    O
after    O
paliperidone    O
,    O
sertindole    O
,    O
amisulpride    B-Aniline114754505
,    O
iloperidone    O
and    O
aripiprazole    O
)    O
.    O

Amisulpride    B-Aniline114754505
(    O
low    O
doses    O
)    O

Tends    O
to    O
produce    O
a    O
moderate    O
amount    O
of    O
sedation    O
,    O
less    O
than    O
clozapine    O
and    O
chlorpromazine    O
but    O
more    O
than    O
aripiprazole    O
,    O
amisulpride    B-Aniline114754505
,    O
paliperidone    O
and    O
sertindole    O
and    O
approximately    O
that    O
of    O
quetiapine    O
and    O
risperidone    O
.    O

Amisulpride    B-Aniline114754505

Amisulpride    B-Aniline114754505

3-Amino-5-nitrosalicylic    B-Aniline114754505
acid    I-Aniline114754505
is    O
an    O
aromatic    O
compound    O
that    O
absorbs    O
light    O
strongly    O
at    O
540    O
nm    O
.    O

Products    O
containing    O
oryzalin    B-Aniline114754505
,    O
benefin    B-Aniline114754505
,    O
or    O
trifluralin    B-Aniline114754505
will    O
provide    O
partial    O
control    O
of    O
germinating    O
seeds    O
.    O

loviride    B-Aniline114754505
(    O
INN    O
)    O

Methyl    O
blue    O
is    O
also    O
available    O
in    O
mixture    O
with    O
water    B-Aniline114754505
blue    I-Aniline114754505
,    O
under    O
name    O
Aniline    O
Blue    O
WS    O
,    O
Aniline    O
blue    O
,    O
China    O
blue    O
,    O
or    O
Soluble    O
blue    O
.    O

After    O
studying    O
and    O
researching    O
the    O
subject    O
,    O
Kahr    O
and    O
associates    O
Yonghong    O
Bing    O
and    O
Werner    O
Kaminsky    O
repeated    O
the    O
experiment    O
in    O
2008    O
,    O
using    O
aniline    B-Aniline114754505
blue    I-Aniline114754505
as    O
the    O
dyeing    O
compound    O
.    O

It    O
is    O
isomeric    O
with    O
"m"-phenylenediamine    B-Aniline114754505
and    O
"p"-phenylenediamine    B-Aniline114754505
,    O
and    O
is    O
commonly    O
referred    O
to    O
as    O
OPD    O
.    O

m    O
"-    O
Phenylenediamine    O
,    B-Aniline114754505
also    I-Aniline114754505
called    I-Aniline114754505
"'1,3-diaminobenzene    I-Aniline114754505
,    O
is    O
an    O
organic    O
compound    O
with    O
the    O
formula    O
C6H4(NH2)2    O
.    O

As    O
a    O
food    O
additive    O
,    O
it    O
has    O
E    O
number    O
E131    B-Aniline114754505
.    O

efonidipine    B-Aniline114754505
(    O
INN    O
)    O

For    O
example    O
,    O
reduction    O
of    O
a    O
1,3-dinitrobenzene    O
derivative    O
using    O
sodium    O
sulfide    O
gives    O
the    O
3-nitroaniline    B-Aniline114754505
.    O

Almost    O
30    O
years    O
after    O
Tröger    O
's    O
initial    O
report    O
,    O
Hünlich    O
described    O
the    O
also    O
mysterious    O
product    O
from    O
the    O
condensation    O
of    O
formaldehyde    O
and    O
2,4-diaminotoluene    B-Aniline114754505
.    O

Amfenac    B-Aniline114754505

4-Aminosalicylic    B-Aniline114754505
acid    I-Aniline114754505
,    O
an    O
antibiotic    O
sold    O
by    O
Jacobus    O
Pharmaceutical    O
under    O
the    O
trademark    O
"    O
Paser    O
"    O

4-Aminosalicylic    B-Aniline114754505
acid    I-Aniline114754505
,    O
also    O
known    O
as    O
para"-    O

aminosalicylic    O
acid    O
("'PAS    B-Aniline114754505
)    O
is    O
an    O
antibiotic    O
primarily    O
used    O
to    O
treat    O
tuberculosis    O
.    O

Aminocarb    B-Aniline114754505

Coomassie    B-Aniline114754505
Brilliant    I-Aniline114754505
Blue    I-Aniline114754505
R-250    O
(    O
CBB)(C45H44N3NaO7S2    O
;    O
mW    O
:    O
825.97    O
)    O
is    O
the    O
most    O
popular    O
protein    O
stain    O
.    O

Coomassie    B-Aniline114754505
Blue    I-Aniline114754505
once    O
binding    O
to    O
proteins    O
elicits    O
a    O
spectrum    O
shift    O
,    O
allowing    O
quantitative    O
dosage    O
.    O

Coomassie    B-Aniline114754505
Brilliant    I-Aniline114754505
Blue    I-Aniline114754505
,    O
a    O
dye    O
commonly    O
used    O
to    O
stain    O
proteins    O
in    O
certain    O
gels    O

Anionic    O
dyes    O
such    O
as    O
Ponceau    O
S    O
and    O
Coomassie    B-Aniline114754505
Brilliant    I-Aniline114754505
Blue    I-Aniline114754505
,    O
and    O
fluorescent    O
dyes    O
like    O
Sypro    O
Ruby    O
and    O
Deep    O
Purple    O
are    O
used    O
before    O
the    O
addition    O
of    O
antibodies    O
.    O

It    O
is    O
obtained    O
by    O
the    O
oxidation    O
of    O
ortho-phenylenediamine    B-Aniline114754505
with    O
ferric    O
chloride    O
.    O

A    O
mixture    O
of    O
"    O
cis"-    O
and    O
"    O
trans"-1,2-diaminocyclohexane    O
is    O
produced    O
by    O
the    O
hydrogenation    O
of    O
"o"-phenylenediamine    B-Aniline114754505
.    O

#    O
The    O
reaction    O
of    O
phenylacetic    O
acid    O
with    O
o-Phenylenediamine    B-Aniline114754505
is    O
used    O
to    O
make    O
Bendazol    O
.    O

"N,N"-dimethyl-"p"-phenylenediamine    B-Aniline114754505
or    O
DMPD    O

In    O
a    O
related    O
process    O
,    O
oxidation    O
of    O
a    O
cold    O
mixture    O
of    O
"para"-aminodimethylaniline    B-Aniline114754505
and    O
"    O
meta    O
"-    O
toluylenediamine    O
gives    O
toluylene    O
blue    O
.    O

Ambroxol    B-Aniline114754505
has    O
recently    O
been    O
shown    O
to    O
increase    O
activity    O
of    O
the    O
lysosomal    O
enzyme    O
glucocerebrosidase    O
.    O

Mucoangin    O
/    O
Mucosolvan    O
(    O
ambroxol    B-Aniline114754505
)    O

Also    O
included    O
are    O
the    O
aromatic    O
nitro-    O
,    O
amino-    O
,    O
and    O
pyridilium    O
-    O
deratives    O
:    O
nitrobenzene    O
,    O
dinitrobenzene    O
,    O
trinitrotoluene    O
,    O
paramethylaminophenol    O
sulfate    O
(    O
Metol    O
)    O
,    O
dinitro    O
-    O
ortho    O
-    O
cresol    O
,    O
aniline    B-Aniline114754505
,    O
trinitrophenylmethylnitramine    O
(    O
tetryl    O
)    O
,    O
hexanitrodiphenylamine    B-Aniline114754505
(    O
aurantia    O
)    O
,    O
phenylenediamines    O
,    O
and    O
paraquat    O
.    O

Phenicarbazide    B-Aniline114754505
is    O
a    O
semicarbazide    O
and    O
an    O
antipyretic    O
substance    O
.    O

On    O
that    O
evidence    O
,    O
it    O
has    O
been    O
used    O
as    O
a    O
replacement    O
for    O
carcinogenic    O
compounds    O
such    O
as    O
benzidine    B-Aniline114754505
and    O
o    O
-    O
phenylenediamine    O
.    O

It    O
is    O
positive    O
in    O
the    O
benzidine    B-Aniline114754505
test    O
and    O
weakly    O
positive    O
in    O
methyl    O
red    O
test    O
.    O

Nikolai    O
Zinin    O
,    O
discovered    O
benzidine    B-Aniline114754505
,    O
co    O
-    O
discovered    O
aniline    B-Aniline114754505
,    O
the    O
first    O
President    O
of    O
the    O
Russian    O
Physical    O
-    O
Chemical    O
Society    O

Other    O
units    O
such    O
as    O
benzidine    B-Aniline114754505
derivatives    O
,    O
viologens    O
groups    O
and    O
fullerenes    O
,    O
have    O
also    O
been    O
utilized    O
in    O
supramolecular    O
electrochemical    O
devices    O
.    O

Metabutoxycaine    B-Aniline114754505

Treatment    O
initially    O
involves    O
the    O
use    O
of    O
medications    O
to    O
eliminate    O
infections    O
(    O
generally    O
antibiotics    O
)    O
and    O
reduce    O
inflammation    O
(    O
generally    O
aminosalicylate    B-Aniline114754505
anti    O
-    O
inflammatory    O
drugs    O
and    O
corticosteroids    O
)    O
.    O

5-ASA    O
compounds    O
,    O
such    O
as    O
mesalazine    B-Aniline114754505
and    O
sulfasalazine    O
,    O
have    O
shown    O
to    O
be    O
of    O
very    O
little    O
efficacy    O
in    O
the    O
treatment    O
of    O
Crohn    O
's    O
disease    O
,    O
either    O
for    O
induction    O
or    O
for    O
maintenance    O
of    O
remission    O
.    O

Mesalazine    B-Aniline114754505

Mesalazine    B-Aniline114754505
(    O
INN    O
,    O
BAN    O
)    O
,    O
also    O
known    O
as    O
mesalamine    B-Aniline114754505
(    O
USAN    O
)    O
or    O
5-aminosalicylic    B-Aniline114754505
acid    I-Aniline114754505
(    O
5-ASA    B-Aniline114754505
)    O
,    O
is    O
an    O
aminosalicylate    O
anti    O
-    O
inflammatory    O
drug    O
used    O
to    O
treat    O
inflammatory    O
bowel    O
disease    O
,    O
including    O
ulcerative    O
colitis    O
,    O
or    O
inflamed    O
anus    O
or    O
rectum    O
,    O
and    O
to    O
maintain    O
remission    O
in    O
Crohn    O
's    O
disease    O
.    O

PAS    O
has    O
also    O
been    O
used    O
in    O
the    O
treatment    O
of    O
inflammatory    O
bowel    O
disease    O
(    O
ulcerative    O
colitis    O
and    O
Crohn    O
's    O
disease    O
)    O
,    O
but    O
has    O
been    O
superseded    O
by    O
other    O
drugs    O
such    O
as    O
sulfasalazine    O
and    O
mesalazine    B-Aniline114754505
.    O

Floctafenine    O
and    O
Glafenine    B-Aniline114754505
are    O
a    O
pair    O
of    O
fenamate    O
NSAIDs    O
whose    O
synthesis    O
rely    O
on    O
the    O
Gould    O
–    O
Jacobs    O
reaction    O
.    O

In    O
part    O
three    O
of    O
the    O
experiment    O
series    O
,    O
polar    O
narcotics    O
phenol    O
,    O
2,4-dimethylphenol    O
,    O
aniline    B-Aniline114754505
,    O
2-chloroaniline    O
and    O
4-chloroaniline    B-Aniline114754505
were    O
evaluated    O
.    O

Renzapride    B-Aniline114754505

an    O
alternate    O
spelling    O
for    O
primuline    B-Aniline114754505
,    O
a    O
dye    O
containing    O
the    O
benzothiazole    O
ring    O
system    O

Besides    O
his    O
role    O
in    O
the    O
formulation    O
of    O
the    O
famous    O
Michaelis    O
–    O
Menten    O
equation    O
(    O
1913    O
)    O
he    O
discovered    O
Janus    B-Aniline114754505
green    I-Aniline114754505
as    O
a    O
supravital    O
stain    O
for    O
mitochondria    O
and    O
the    O
Michaelis    O
–    O
Gutmann    O
body    O
in    O
urinary    O
tract    O
infections    O
(    O
1902    O
)    O
and    O
found    O
that    O
thioglycolic    O
acid    O
could    O
dissolve    O
keratin    O
,    O
a    O
discovery    O
that    O
would    O
come    O
to    O
have    O
several    O
implications    O
in    O
the    O
cosmetic    O
industry    O
,    O
including    O
the    O
permanent    O
wave    O
.    O

Methyl    B-Aniline114754505
violet    I-Aniline114754505
can    O
be    O
formulated    O
to    O
change    O
from    O
orange    O
to    O
green    O
,    O
or    O
orange    O
to    O
colorless    O
.    O

Image    O
:    O
Methyl    O
Violet    O
Methyl    B-Aniline114754505
violet    I-Aniline114754505
2B    O

Image    O
:    O
Methyl    O
Violet    O
Methyl    B-Aniline114754505
violet    I-Aniline114754505
6B    O

Often    O
orcein    O
or    O
a    O
combination    O
of    O
resorcinol    O
and    O
fuchsine    B-Aniline114754505
are    O
used    O
for    O
staining    O
.    O

François    O
-    O
Emmanuel    O
Verguin    O
,    O
chemist    O
having    O
synthesized    O
Fuchsine    B-Aniline114754505
;    O

Using    O
that    O
along    O
with    O
a    O
new    O
staining    O
technique    O
of    O
applying    O
acid    O
-    O
fuchsin    B-Aniline114754505
contrasted    O
by    O
picric    O
acid    O
amid    O
delicate    O
heating    O
,    O
he    O
observed    O
filaments    O
in    O
the    O
nearly    O
all    O
cell    O
types    O
,    O
developed    O
from    O
granules    O
.    O

In    O
turn    O
,    O
the    O
latter    O
reacted    O
with    O
a    O
fuchsine    B-Aniline114754505
-    O
sulfurous    O
acid    O
stain    O
used    O
in    O
this    O
nuclear    O
staining    O
method    O
and    O
gave    O
rise    O
to    O
colored    O
compounds    O
inside    O
the    O
cytoplasm    O
of    O
the    O
cells    O
.    O

File    O
:    O
Rosaniline    O
Fuchsine    B-Aniline114754505
(    O
hydrochloride    O
salt    O
)    O

0.03    O
%    O
fuchsine    B-Aniline114754505

3,4-Xylidine    B-Aniline114754505
is    O
an    O
organic    O
compound    O
with    O
the    O
formula    O
C6H3(CH3)2NH2    O
.    O

Green    B-Aniline114754505
S    I-Aniline114754505
(    O
E142    O
)    O
is    O
prohibited    O
in    O
many    O
countries    O
,    O
for    O
it    O
is    O
known    O
to    O
cause    O
hyperactivity    O
,    O
asthma    O
,    O
urticaria    O
,    O
and    O
insomnia    O
.    O

Lapatinib    B-Aniline114754505
(    O
Tykerb    O
)    O

Important    O
role    O
(    O
David    O
Cameron    O
as    O
joint    O
global    O
Chief    O
Investigator    O
)    O
in    O
the    O
pivotal    O
clinical    O
trial    O
that    O
tested    O
the    O
hypothesis    O
that    O
the    O
combination    O
of    O
lapatinib    B-Aniline114754505
and    O
the    O
cytotoxic    O
drug    O
capecitabine    O
would    O
be    O
superior    O
to    O
capecitabine    O
alone    O
in    O
patients    O
with    O
HER2    O
+    O
metastatic    O
breast    O
cancer    O
that    O
had    O
progressed    O
despite    O
trastuzumab    O
treatment    O
.    O

The    O
results    O
of    O
this    O
trial    O
has    O
led    O
to    O
a    O
global    O
(    O
more    O
than    O
100    O
countries    O
)    O
marketing    O
authorisation    O
of    O
the    O
drug    O
lapatinib    B-Aniline114754505
produced    O
by    O
the    O
pharmaceutical    O
company    O
GlaxoSmithKline    O
.    O

4'-Aminopropiophenone    B-Aniline114754505

Hexanitrobenzene    O
,    O
also    O
known    O
as    O
HNB    O
,    O
is    O
a    O
high    O
-    O
density    O
explosive    O
compound    O
with    O
chemical    O
formula    O
C6N6O12    O
,    O
obtained    O
by    O
oxidizing    O
the    O
amine    O
group    O
of    O
pentanitroaniline    B-Aniline114754505
with    O
hydrogen    O
peroxide    O
in    O
sulfuric    O
acid    O
.    O

Nitrophenols    O
like    O
bromethalin    B-Aniline114754505
and    O
2,4-dinitrophenol    O
(    O
cause    O
high    O
fever    O
and    O
brain    O
swelling    O
,    O
no    O
known    O
antidote    O
)    O

The    O
rocket    O
burned    O
a    O
hypergolic    O
mixture    O
of    O
S    O
-    O
Stoff    O
(    O
nitric    O
acid    O
with    O
5%    O
iron(III    O
)    O
chloride    O
)    O
and    O
R    O
-    O
Stoff    O
(    O
an    O
organic    O
amine    O
-    O
mixture    O
of    O
50%    O
dimethylaminobenzene    B-Aniline114754505
and    O
50%    O
triethylamine    O
called    O
Tonka    O
250    O
)    O
as    O
propellant    O
,    O
delivering    O
thrust    O
initially    O
,    O
declining    O
to    O
over    O
the    O
17-second    O
burn    O
.    O

After    O
they    O
burn    O
out    O
and    O
drop    O
away    O
(    O
between    O
3    O
and    O
5.1    O
seconds    O
from    O
launch    O
)    O
it    O
fires    O
a    O
5D67    O
liquid    O
fueled    O
sustainer    O
rocket    O
engine    O
(    O
for    O
51–150    O
seconds    O
)    O
which    O
burns    O
a    O
fuel    O
called    O
TG-02    O
Samin    O
(    O
50%    O
xylidine    B-Aniline114754505
and    O
50%    O
triethylamine    O
)    O
,    O
oxidized    O
by    O
an    O
agent    O
called    O
AK-27P    O
Melange    O
(    O
red    O
fuming    O
nitric    O
acid    O
enriched    O
with    O
nitrogen    O
oxides    O
,    O
phosphoric    O
acid    O
and    O
hydrofluoric    O
acid    O
)    O
.    O

Diethylamino    B-Aniline114754505
hydroxybenzoyl    I-Aniline114754505
hexyl    I-Aniline114754505
benzoate    I-Aniline114754505
(    O
Uvinul    O
A    O
Plus    O
)    O

These    O
effects    O
can    O
be    O
caused    O
by    O
solvents    O
,    O
or    O
by    O
pigment    O
ingredients    O
such    O
as    O
"p"-Anisidine    B-Aniline114754505
,    O
which    O
helps    O
create    O
some    O
inks    O
'    O
color    O
and    O
shine    O
.    O

melarsoprol    B-Aniline114754505

The    O
related    O
drug    O
Melarsoprol    B-Aniline114754505
is    O
still    O
in    O
use    O
against    O
late    O
-    O
state    O
African    O
trypanosomiasis    O
(    O
sleeping    O
sickness    O
)    O
,    O
despite    O
its    O
high    O
toxicity    O
and    O
possibly    O
fatal    O
side    O
effects    O
.    O

Melarsoprol    B-Aniline114754505
(    O
for    O
treatment    O
of    O
sleeping    O
sickness    O
caused    O
by    O
"    O
Trypanosoma    O
brucei    O
"    O
)    O

The    O
toxicity    O
of    O
Asulam    B-Aniline114754505
is    O
low    O
and    O
has    O
been    O
generally    O
highly    O
cost    O
-    O
effective    O
but    O
its    O
use    O
is    O
now    O
restricted    O
by    O
the    O
EU    O
after    O
2012    O
,    O
at    O
least    O
until    O
specific    O
registered    O
uses    O
can    O
be    O
defined    O
.    O

morniflumate    B-Aniline114754505
(    O
INN    O
)    O

Although    O
no    O
MKK1/2    O
or    O
ERK1/2    O
inhibitors    O
were    O
developed    O
for    O
clinical    O
use    O
,    O
kinase    O
inhibitors    O
that    O
also    O
inhibit    O
Raf    O
kinases    O
(    O
e.g.    O
Sorafenib    B-Aniline114754505
)    O
are    O
successful    O
antineoplastic    O
agents    O
against    O
various    O
types    O
of    O
cancer    O
.    O

sorafenib    B-Aniline114754505
(    O
protein    O
kinase    O
inhibitor    O
)    O

sorafenib    B-Aniline114754505
a    O
combined    O
Tyrosine    O
protein    O
kinases    O
inhibitor    O
.    O

sorafenib    B-Aniline114754505
(    O
tyrosine    O
kinase    O
inhibitor    O
)    O

Sorafenib    B-Aniline114754505
(    O
Nexavar    O
)    O

In    O
2013    O
some    O
controversy    O
was    O
sparked    O
during    O
a    O
Financial    O
Times    O
panel    O
discussion    O
with    O
relation    O
to    O
Bayer    O
's    O
kidney    O
and    O
liver    O
cancer    O
drug    O
Nexavar    B-Aniline114754505
.    O

Because    O
most    O
systemic    O
drugs    O
have    O
no    O
efficacy    O
in    O
the    O
treatment    O
of    O
HCC    O
,    O
research    O
into    O
the    O
molecular    O
pathways    O
involved    O
in    O
the    O
production    O
of    O
liver    O
cancer    O
produced    O
sorafenib    B-Aniline114754505
,    O
a    O
targeted    O
therapy    O
drug    O
that    O
prevents    O
cell    O
proliferation    O
and    O
blood    O
cell    O
growth    O
.    O

It    O
is    O
also    O
the    O
active    O
component    O
of    O
the    O
prodrug    O
balsalazide    B-Aniline114754505
along    O
with    O
the    O
inert    O
carrier    O
molecule    O
4-aminobenzoyl    O
-    O
beta    O
-    O
alanine    O
.    O

"m"-Anisidine    B-Aniline114754505
(    O
3-methoxyaniline    O
)    O

Bosutinib    B-Aniline114754505
's    O
structure    O
is    O
based    O
on    O
a    O
quinoline    O
scaffold    O
and    O
is    O
structurally    O
related    O
to    O
the    O
AstraZeneca    O
quinazoline    O
template    O
.    O

From    O
2006    O
to    O
2011    O
Dr.    O
Gambacorti    O
-    O
Passerini    O
was    O
the    O
first    O
researcher    O
to    O
develop    O
at    O
preclinical    O
and    O
clinical    O
level    O
another    O
drug    O
for    O
CML    O
named    O
bosutinib    B-Aniline114754505
.    O

However    O
,    O
for    O
some    O
highly    O
potent    O
toxins    O
(    O
ex    O
.    O
lofentanil    B-Aniline114754505
,    O

Phenampromide    O
is    O
an    O
opioid    O
analgesic    O
from    O
the    O
ampromide    O
family    O
of    O
drugs    O
,    O
related    O
to    O
other    O
drugs    O
such    O
as    O
propiram    O
and    O
diampromide    B-Aniline114754505
.    O

Diampromide    B-Aniline114754505
is    O
an    O
opioid    O
analgesic    O
from    O
the    O
ampromide    O
family    O
of    O
drugs    O
,    O
related    O
to    O
other    O
drugs    O
such    O
as    O
propiram    O
.    O

o    O
"-    O
Anisidine    O
("'2-anisidine    B-Aniline114754505
)    O
is    O
a    O
yellow    O
liquid    O
with    O
a    O
melting    O
point    O
of    O
−1    O
to    O
5    O
°C    O
and    O
a    O
density    O
of    O
1.09    O
g    O
/    O
cm3    O
.    O

Insensitive    O
munitions    O
are    O
almost    O
always    O
filled    O
with    O
fire    O
resistant    O
,    O
shock    O
resistant    O
insensitive    O
high    O
explosives    O
(    O
IHE    O
)    O
such    O
as    O
triaminotrinitrobenzene    O
(    O
TATB    B-Aniline114754505
)    O
or    O
various    O
insensitive    O
explosive    O
mixtures    O
,    O
or    O
plastic    O
/    O
polymer    O
-    O
bonded    O
explosives    O
,    O
which    O
are    O
similar    O
to    O
reactive    O
materials    O
.    O

These    O
are    O
almost    O
exclusively    O
TATB    B-Aniline114754505
plastic    O
bonded    O
explosive    O
(    O
LX-17    O
-    O
0    O
and    O
PBX-9502    O
)    O
.    O

The    O
risk    O
of    O
accidental    O
direct    O
detonation    O
is    O
significantly    O
reduced    O
by    O
using    O
insensitive    O
high    O
explosives    O
such    O
as    O
TATB    B-Aniline114754505
,    O
which    O
is    O
extremely    O
unlikely    O
to    O
detonate    O
due    O
to    O
fire    O
or    O
impact    O
or    O
electricity    O
.    O

Oxybuprocaine    B-Aniline114754505

Benoxinate    B-Aniline114754505
,    O
a    O
local    O
anaesthetic    O
agent    O

Prednimustine    B-Aniline114754505

Prednimustine    B-Aniline114754505
(    O
prednisolone    O
chlorambucil    O
ester    O
)    O

Among    O
the    O
13    O
newly    O
added    O
SVHCs    O
on    O
June    O
18    O
,    O
2012    O
,    O
four    O
of    O
them    O
(    O
C.I.    O
Basic    O
Violet    O
3    O
,    O
C.I.    O
Basic    O
Blue    O
26    O
,    O
C.I.    O
Solvent    O
Blue    O
4    O
and    O
4,4'-bis(dimethylamino)-4'-(methylamino)trityl    O
alcohol    O
)    O
are    O
identified    O
as    O
SVHC    O
only    O
if    O
the    O
presence    O
of    O
the    O
carcinogenic    O
constituents    O
Michler's    B-Aniline114754505
ketone    I-Aniline114754505
or    O
Michler    O
's    O
base    O
is    O
≥    O
0.1%    O
w    O
/    O
w    O
.    O

Quadricyclane    O
is    O
produced    O
by    O
the    O
irradiation    O
of    O
norbornadiene    O
(    O
bicyclo[2.2.1]hepta-2,5-diene    O
)    O
in    O
the    O
presence    O
of    O
Michler's    B-Aniline114754505
ketone    I-Aniline114754505
or    O
ethyl    O
Michler    O
's    O
ketone    O
.    O

Mesitylene    O
is    O
mainly    O
used    O
as    O
a    O
precursor    O
to    O
2,4,6-trimethylaniline    B-Aniline114754505
,    O
a    O
precursor    O
to    O
colorants    O
.    O

"N"-Phenylnaphthalen-1-amine    B-Aniline114754505

PRX-07034    B-Aniline114754505
is    O
a    O
selective    O
5-HT6    O
receptor    O
antagonist    O
.    O

RS-67333    B-Aniline114754505

Bromantane    B-Aniline114754505
,    O
sold    O
under    O
the    O
brand    O
name    O
Ladasten    B-Aniline114754505
,    O
is    O
an    O
atypical    O
psychostimulant    O
and    O
anxiolytic    O
drug    O
of    O
the    O
adamantane    O
family    O
related    O
to    O
amantadine    O
and    O
memantine    O
which    O
is    O
used    O
in    O
Russia    O
in    O
the    O
treatment    O
of    O
neurasthenia    O
.    O

Bromantane    B-Aniline114754505

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
(    O
hydroxyamino)benzene    O
,    O
and    O
one    O
product    O
,    O
2-aminophenol    B-Aniline114754505
.    O

Studies    O
conclude    O
that    O
HDAC    O
inhibitors    O
such    O
as    O
trichostatin    B-Aniline114754505
A    I-Aniline114754505
(    O
TSA    O
)    O
increase    O
histone    O
acetylation    O
and    O
improve    O
synaptic    O
plasticity    O
and    O
long    O
-    O
term    O
memory    O
(    O
Fig    O
1A    O
)    O
.    O

Trichostatin    B-Aniline114754505
A    I-Aniline114754505
(    O
TsA    O
)    O
is    O
an    O
HDAC    O
inhibitor    O
associated    O
with    O
reduced    O
cocaine    O
-    O
seeking    O
behaviors    O
;    O
it    O
inhibits    O
HDAC    O
classes    O
1    O
,    O
3    O
,    O
4    O
,    O
6    O
,    O
and    O
10    O
.    O

For    O
each    O
gene    O
,    O
researchers    O
verified    O
dependency    O
of    O
their    O
expression    O
on    O
the    O
D1    O
receptor    O
after    O
cocaine    O
treatment    O
using    O
Trichostatin    B-Aniline114754505
A    I-Aniline114754505
or    O
other    O
receptor    O
antagonists    O
.    O

New    B-Aniline114754505
fuchsine    I-Aniline114754505
(    O
As    O
chloride    O
)    O

Phenacaine    B-Aniline114754505

"    O
m    O
"-    O
Cresidine    B-Aniline114754505

Other    O
ingredients    O
include    O
dicalcium    O
phosphate    O
,    O
microcrystalline    O
cellulose    O
,    O
croscarmellose    O
sodium    O
,    O
stearic    O
acid    O
,    O
film    O
coating    O
(    O
dextrin    O
)    O
,    O
titanium    O
dioxide    O
,    O
hydroxypropylmethyl    O
cellulose    O
,    O
Brilliant    B-Aniline114754505
Blue    I-Aniline114754505
FCF    I-Aniline114754505
,    O
aluminum    O
lake    O
,    O
Macrogol    O
/    O
PEG    O
8000    O
,    O
dextrose    O
monohydrate    O
,    O
lecithin    O
,    O
maltodextrin    O
,    O
Macrogol    O
/    O
PEG    O
400    O
,    O
magnesium    O
stearate    O
,    O
and    O
silica    O
.    O

Artificial    O
colors    O
(    O
Yellow    O
6    O
,    O
Blue    B-Aniline114754505
1    I-Aniline114754505
,    O
Yellow    O
5    O
and    O
Red    O
40    O
)    O

Image    O
:    O
Brilliant    O
Blue    O
Brilliant    B-Aniline114754505
Blue    I-Aniline114754505
FCF    I-Aniline114754505
,    O
a    O
common    O
food    O
colorant    O
.    O

4-Aminophenol    B-Aniline114754505
derivatives    O

Chemically    O
,    O
it    O
is    O
the    O
amide    O
formed    O
from    O
4-aminophenol    B-Aniline114754505
and    O
arachidonic    O
acid    O
.    O

Phenylhydroxylamine    O
is    O
unstable    O
to    O
heating    O
,    O
and    O
in    O
the    O
presence    O
of    O
strong    O
acids    O
easily    O
rearranges    O
to    O
4-aminophenol    B-Aniline114754505
.    O

Some    O
combination    O
of    O
miltefosine    O
,    O
paramycin    B-Aniline114754505
and    O
liposomal    O
amphotericin    O
B    O
,    O
however    O
,    O
may    O
be    O
recommended    O
due    O
to    O
issues    O
with    O
resistance    O
.    O

Aminosalicylic    B-Aniline114754505
acid    I-Aniline114754505

Noninfectious    O
inflammatory    O
processes    O
include    O
surgery    O
,    O
intrathecal    O
hemorrhage    O
,    O
and    O
the    O
administration    O
of    O
intrathecal    O
(    O
inside    O
the    O
dural    O
canal    O
)    O
agents    O
such    O
as    O
myelographic    O
contrast    O
media    O
,    O
anesthetics    O
(    O
e.g.    O
chloroprocaine    B-Aniline114754505
)    O
,    O
and    O
steroids    O
(    O
e.g.    O
Depo    O
-    O
Medrol    O
,    O
Kenalog    O
)    O
.    O

The    O
pudendal    O
block    O
gets    O
its    O
name    O
because    O
a    O
local    O
anesthetic    O
,    O
such    O
as    O
lidocaine    O
or    O
chloroprocaine    B-Aniline114754505
,    O
is    O
injected    O
into    O
the    O
pudendal    O
canal    O
where    O
the    O
pudendal    O
nerve    O
is    O
located    O
.    O

Other    O
drugs    O
used    O
for    O
ventricular    O
arrhythmia    O
include    O
lidocaine    O
,    O
amiodarone    O
,    O
bretylium    O
,    O
flecainide    O
,    O
procainamide    B-Aniline114754505
,    O
and    O
mexiletine    O
.    O

There    O
are    O
38    O
known    O
medications    O
to    O
cause    O
DIL    O
but    O
there    O
are    O
three    O
that    O
report    O
the    O
highest    O
number    O
of    O
cases    O
:    O
hydralazine    O
,    O
procainamide    B-Aniline114754505
,    O
and    O
isoniazid    O
.    O

Procainamide    B-Aniline114754505
(    O
antiarrhythmic    O
)    O

Procainamide    B-Aniline114754505

Class    O
Ia    O
—    O
Fast    O
sodium    O
channels    O
(    O
quinidine    O
,    O
ajmaline    O
,    O
procainamide    B-Aniline114754505
,    O
disopyramide    O
)    O

Other    O
drugs    O
used    O
for    O
ventricular    O
arrhythmia    O
include    O
lidocaine    O
,    O
amiodarone    O
,    O
bretylium    O
,    O
flecainide    O
,    O
procainamide    B-Aniline114754505
,    O
and    O
mexiletine    O
.    O


